drugs final

Pharmacotherapy

The treatment of a disease through the use of drugs.

Psychotherapy

The treatment of mental disorders through psychological methods.

Major Depressive Disorder (MDD)

A debilitating condition characterized by overwhelming sadness, feelings of worthlessness, and loss of interest in normally pleasurable activities.

Negative Cognitive Triad

A concept in cognitive psychology that describes a pattern of negative thinking about oneself, the world, and the future.

Brain-Derived Neurotrophic Factor (BDNF)

A protein associated with the growth, maintenance, and survival of neurons, particularly important in the context of depression.

HPA Axis

The hypothalamic-pituitary-adrenal axis, a central part of the body's stress response system.

Neurogenesis

The process of generating new neurons in the brain.

Cognitive Behavioral Therapy (CBT)

A type of psychotherapy that helps patients understand the thoughts and feelings that influence behaviors.

Comorbidity

The simultaneous presence of two or more diseases or medical conditions in a patient.

Corticotropin-Releasing Factor (CRF)

A peptide involved in the stress response, released by the hypothalamus to promote the release of ACTH from the pituitary gland.

Major Depressive Disorder

A mental health disorder characterized by persistent sadness, loss of interest or pleasure, and other symptoms that impair daily functioning.

Symptoms of Major Depressive Disorder

Include sadness, lack of motivation, fatigue, disrupted sleep, changes in appetite, and recurrent thoughts of death.

Antidepressant

A class of medications used to treat major depressive disorder, which includes several subclasses.

SSRIs

Selective Serotonin Reuptake Inhibitors, a type of antidepressant that works by blocking the reuptake of serotonin.

TCA

Tricyclic Antidepressants, which block reuptake of serotonin and norepinephrine, potentially leading to various side effects.

MAOIs

Monoamine Oxidase Inhibitors, a type of antidepressant that inhibits the enzyme responsible for breaking down neurotransmitters.

Discontinuation Syndrome

A condition that can occur when a patient abruptly stops taking an SSRI, characterized by flu-like symptoms, insomnia, and sensory disturbances.

Wine and Cheese Effect

A potentially dangerous reaction associated with MAOIs due to the consumption of tyramine-rich foods, leading to increased blood pressure.

Efficacy of SSRIs

SSRIs are slightly effective in treating severe depression but no more effective than placebo for mild to moderate depression.

Fetal Effects of Antidepressants

Concerns regarding the use of antidepressants during pregnancy, including risks of low birth weight and neonatal withdrawal symptoms.

Suicidality in Youth

Increased risk of suicidal thoughts and behavior noted in children and adolescents taking antidepressants.

Screening for Depression

The rates of diagnosis for depression significantly dropped after public health warnings about antidepressant risks in children.

Serotonin Syndrome

A potentially fatal condition resulting from high doses of SSRIs or the combination of SSRIs with other serotonergic drugs.

Psychotherapy and Pharmacotherapy

Combining psychotherapy with medications may improve treatment outcomes and lower relapse rates.

Withdrawal Symptoms

Symptoms experienced upon discontinuation of antidepressants, which may include anxiety, insomnia, and flu-like symptoms.

Cognitive Behavioral Therapy (CBT)

A form of psychotherapy that may enhance the effects of antidepressant medications and reduce the risk of relapse.

Pharmacotherapy

A treatment approach that uses medication to manage psychological disorders.

Psychotherapy

A treatment approach involving psychological techniques to address mental health issues.

Nocebo effect

Negative expectations leading to negative outcomes in treatment.

Combination Therapy

The use of both medication and psychotherapy in treatment for better efficacy.

Major Depressive Disorder (MDD)

A common disabling psychiatric illness characterized by overwhelming sadness and loss of interest.

Antidepressants

Medications used to treat depression that may increase neurogenesis.

Therapeutic lag

The delay between the onset of drug action and the observable effects of the treatment.

Monoamine theory

A theory suggesting that low levels of neurotransmitters such as serotonin are the primary cause of depression.

Negative Cognitive Triad

A concept by Beck that describes a negative view of the self, the world, and the future.

BDNF (Brain-Derived Neurotrophic Factor)

A protein vital for neuron survival and synaptic plasticity; low levels are associated with depression.

SSRI (Selective Serotonin Reuptake Inhibitors)

A class of antidepressants that works by blocking the reuptake of serotonin.

Serotonin Syndrome

A potentially life-threatening condition caused by excessive serotonin levels in the body.

Efficacy

The ability of a treatment to produce a beneficial effect under controlled conditions.

Meta-Analysis

A statistical analysis that combines the results of multiple scientific studies.

Cognitive Behavioral Therapy (CBT)

A type of psychotherapy focused on modifying dysfunctional emotions, behaviors, and thoughts.

Comorbidity

The presence of one or more additional disorders co-occurring with a primary disorder.